Friedman, The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women. Familial Cancer 8, 399 (Dec, 2009).Menachem TD, Laitman Y, Kaufman B, Friedman E: The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in ...
9 of the 13 Jewish women (69%) with a BRCA mutation had BSO, as did 1 of 2 non-Jewish women. These preliminary data suggest that women with BRCA mutations participate in appropriate preventive strategies for ovarian cancer; most choosing prophylactic BSO. Jewish patients were more likely to ...
Ovarian cancer is the fifth most common cancer in women and is the most lethal of all gynecologic cancers. Early-stage ovarian cancer is curable while women who are diagnosed with advanced ovarian cancer continue to have poor long-term survival due to recurrence of disease. Unfortunately, most ...
In the US, ovarian cancer is the second most common gynecologic cancer and has the highest mortality rate of any gynecologic cancer. Incidence increases with age (peak incidence at 55–64 years of...
are Caucasian, especially of Northern European or Ashkenazi Jewish descent, are over 50 (half of all diagnosed cases are in women over 65), have a family history of breast, ovarian, endometrial (uterine), prostate, or colon cancer,
Inflammation is a key contributor to ovarian cancer cell seeding(炎症是卵巢癌细胞播种的关键因素) 热度: Version2.2011,11/15/10©NationalComprehensiveCancerNetwork,Inc.2010,Allrightsreserved.TheNCCNGuidelines™andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®. ...
Women with inherited mutations in the BRCA1 or BRCA2 genes have increased lifetime risks for developing breast and/or ovarian cancer and may develop these cancers around the age of 30 years. Therefore, prevention of breast and ovarian cancer in these women may need to start relatively early in...
Results were similar for PFS and ovarian cancer-specific survival. In analyses stratified by histologic subtype, associations were strongest for women with low-grade serous (pHR: 1.12 per 5 kg m−2) and endometrioid subtypes (pHR: 1.08 per 5 kg m−2), and more modest for the ...
Conclusion Racial disparities in availability and utilization of healthcare resources likely contributes to adverse epithelial ovarian cancer outcomes among Black women in the US.Background Ovarian cancer is the leading cause of death from gynecological malignancies in the US [1, 2] and the fifth most...
A study led by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) in collaboration with the Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and the Jewish General Hospital; suggests that all women with ovarian cancer should be ...